SCHEMBL18870484

SCHEMBL18870484

COc1ccc(C(C)O)c2c1C1(CCCC1)CC2

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
LMNA P02545 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
ADRA1A P35348 3/20 0.33
ADRA2A P08913 3/20 0.33
CYP2D6 P10635 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA7 P43166 1/20 0.33
CA9 Q16790 1/20 0.33
MAPK1 P28482 1/20 0.33
BLM P54132 1/20 0.33
AOC3 Q16853 1/20 0.31
PARP1 P09874 1/20 0.31
PDE7A Q13946 1/20 0.31
ALDH1A1 P00352 1/20 0.31
ADRB2 P07550 1/20 0.31
ADRB1 P08588 1/20 0.31
ADRB3 P13945 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17014327 0.81 ADRA1A (0.41) LMNAADRA1AADRA2APARP1PDE7A
SCHEMBL17014455 0.78 ADRA1A (0.41) ADRA1AADRA2APARP1ALDH1A1PDE4A
SCHEMBL17014347 0.76 LMNA (0.37) MEN1KMT2ALMNAL3MBTL1ADRA1A
SCHEMBL17014346 0.74 LMNA (0.43) MEN1KMT2ALMNAL3MBTL1ADRA1A
SCHEMBL17014463 0.72 ADRA1A (0.45) ADRA1AADRA2ACA1CA2PARP1
SCHEMBL17014374 0.70 ADRA2A (0.36) ADRA1AADRA2AALDH1A1PDE4A
SCHEMBL5722922 0.69 PDE4D (0.45) MEN1KMT2ALMNAL3MBTL1CA1
SCHEMBL17014343 0.67 HTR5A (0.47) MEN1KMT2AADRA2ACA1CA2
SCHEMBL29862053 0.66 HTR5A (0.46) ADRA2AALDH1A1
SCHEMBL17014372 0.66 ALDH1A1 (0.48) ADRA2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2900656-B1 SPIRO RING COMPOUNDS AS HEPATITIS C VIRUS (HCV) INHIBITORS SUNSHINE LAKE PHARMA CO LTD (CN) 2017-05-17 EP disclosed